• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    With Obamacare reform out of the national limelight, for now, Congress should be looking for bold new ideas to make healthcare more affordable. (AP Photo/Patrick Sison)
    Beltway Confidential

    On prescription drugs, patients must be ‘free to choose’

    Casey Given -
    August 23, 2017 6:30 pm
    0
    Mylan has agreed to repay $465 million to the federal government for overbilling for its lifesaving EpiPen allergy antidote. The settlement comes at the end of an investigation that found Mylan avoided paying state Medicaid programs higher rebates for the EpiPen by improperly naming it as a generic medication. (AP Photo/Pablo Martinez Monsivais, File)
    Healthcare

    Mylan agrees to pay back government $465 million for EpiPen overbilling

    Kimberly Leonard -
    August 17, 2017 8:01 pm
    0
    Reps. Elijah Cummings, D-Md., and Peter Welch, D-Vt., sent letters to seven drug makers seeking answers about price hikes for MS drugs. (AP Photo/Pablo Martinez Monsivais)
    Healthcare

    Democrats accuse multiple sclerosis drugmakers of ‘shadow pricing’

    Robert King -
    August 17, 2017 3:15 pm
    0
    Manufacturers did 38 trials for the 22 drugs approved through the FDA's expedited approval process. Of those trials, only 19 were completed within three years. (AP Photo/Gregory Bull)
    Healthcare

    Speedy drug approvals lacking in follow-up

    Robert King -
    August 16, 2017 8:39 pm
    0
    South Carolina is suing the maker of popular painkiller Oxycontin for deceptively marketing the addictive opioid. (AP Photo/Toby Talbot, File)
    Healthcare

    South Carolina sues Oxycontin maker

    Robert King -
    August 15, 2017 3:31 pm
    0
    Martin Shkreli, the drug CEO, said Tuesday that he was told that he was targeted by government authorities because he was too
    Crime

    Martin Shkreli: I was targeted for being ‘flamboyant and personable’

    Pete Kasperowicz -
    August 15, 2017 1:06 pm
    0
    Shares of pharmaceutical giant Merck rose slightly Monday morning after President Trump slammed high drug prices in response to the company's CEO resigning from the White House's manufacturing council. (AP Photo/Mel Evans)
    Healthcare

    The Trump bump: Merck shares rise after tweet

    Kimberly Leonard -
    August 14, 2017 3:15 pm
    0
    News

    Trump slams Merck’s ‘ripoff drug prices’ after CEO resigns from manufacturing council

    Melissa Quinn -
    August 14, 2017 1:11 pm
    0
    New Hampshire on Tuesday became the latest state to launch a lawsuit against a prescription painkiller manufacturer, Perdue Pharma, for deceptively marketing OxyContin. (AP Photo/Toby Talbot, File)
    Healthcare

    New Hampshire sues opioid makers for deceptive marketing

    Kimberly Leonard -
    August 9, 2017 3:39 pm
    0
    Shkreli is charged with using an investment fund to prop up the earnings for the Retrophin. (AP Photo/Susan Walsh, File)
    Crime

    Martin Shkreli leaves a legacy on Capitol Hill

    Robert King -
    August 5, 2017 12:22 am
    0
    1...106107108...156Page 107 of 156
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.